South Miami, FL

MedEye Associates

Hypertension

Edema

Ocular Hypertension

Retinal Artery Occlusion

Arterial Occlusive Diseases

Open-Angle Glaucoma

Macular Edema

Diabetic Retinopathy

Glaucoma

KUS121

Bimatoprost

THR-149

Allergan

Kyoto Drug Discovery and Development Co., Ltd.

Oxurion

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

Central retinal artery occlusion (CRAO) is an ophthalmologic emergency which leads to severe and permanent vision loss. There is no evidence-based therapy for CRAO. The objective of this GION study is to evaluate the efficacy and safety of KUS121 intravitreal (IVT) injection in participants with acute non-arteritic CRAO.

A Study of the Efficacy and Safety of KUS121 in Participants With Acute Non-Arteritic Central Retinal Artery Occlusion (CRAO)

MedEye Associates | South Miami, FL

Site insights

Work at this site?

Active trials

A Study of the Efficacy and Safety of KUS121 in Participants With Acute Non-Arteritic Central Retinal Artery Occlusion (CRAO) (GION)

Trial sponsors